Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3526-3528

  Nagura, Jun ^a   Kijima, Koji ^a   Kurazono, Mizuyo ^a   Takahata, Sho ^a   Sugano, Toshie ^a   Tanaka, Yukari ^a   Hirai, Yoko ^a   Yamada, Keiko ^a   Takayama, Yoshihiro ^a   Shitara, Eiki ^a   Yonezawa, Minoru ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CILASTATIN; ME 1036; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG PROTEIN BINDING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 23044515843     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3526-3528.2005     Document Type: Article

References (11)

1. Abraham, J., C. Mansour, E. Veledar, B. Khan, and S. Lerakis. 2004. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S. aureus bacteremia. Am. Heart J. 147:536-539.
2. Bonow, R. O., B. Carabello, A. C. de Leon, L. H. Edmunds, Jr., B. J. Fedderly, M. D. Freed, W. H. Gaasch, C. R. McKay, R. A. Nishimura, P. T. O'Gara, R. A. O'Rourke, S. H. Rahimtoola, J. L. Ritchie, M. D. Cheitlin, K. A. Eagle, T. J. Gardner, A. Garson, Jr., R. J. Gibbons, R. O. Russell, T. J. Ryan, and S. C. Smith, Jr. 1998. ACC/AHA guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease). J. Heart Valve Dis. 7:672-707.
3. Durack, D. T., and P. B. Beeson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:44-49.
4. Kurazono, M., T. Ida, K. Yamada, Y. Hirai, T. Maruyama, E. Shitara, and M. Yonezawa. 2004. In vitro antibacterial activities of ME1036 (CP5609), a novel parenteral carbapenem active against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 48:2831-2837.
5. Lefort, A., and B. Fantin. 1999. Rabbit model of bacterial endocarditis, p. 611-617. In O. Zak and M. A. Sande (ed.), Handbook of animal models of infection. Academic Press, Inc., New York, N.Y.
6. Mylonakis, E., and S. B. Calderwood. 2001. Infective endocarditis in adults. N. Engl. J. Med. 345:1318-1330.
7. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Perlman, B. B., and L. R. Freedman. 1971. Experimental endocarditis. 2. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 44:206-213.
9. Sandre, R. M., and S. D. Shafran. 1996. Infective endocarditis: review of 135 cases over 9 years. Clin. Infect. Dis. 22:276-286.
10. Sorrell, T. C., D. R. Packham, S. Shanker, M. Foldes, and R. Munro. 1982. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann. Intern. Med. 97:344-350.
11. Stefani, S., and P. E. Varaldo. 2003. Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9:1179-1186.